Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Roles of purinergic P2X7 receptor in glioma and microglia in brain tumors.

McLarnon JG.

Cancer Lett. 2017 Aug 28;402:93-99. doi: 10.1016/j.canlet.2017.05.004. Epub 2017 May 20. Review.

PMID:
28536012
2.
3.

Pharmacological antagonism of interleukin-8 receptor CXCR2 inhibits inflammatory reactivity and is neuroprotective in an animal model of Alzheimer's disease.

Ryu JK, Cho T, Choi HB, Jantaratnotai N, McLarnon JG.

J Neuroinflammation. 2015 Aug 9;12:144. doi: 10.1186/s12974-015-0339-z.

4.

Correlated inflammatory responses and neurodegeneration in peptide-injected animal models of Alzheimer's disease.

McLarnon JG.

Biomed Res Int. 2014;2014:923670. doi: 10.1155/2014/923670. Epub 2014 Apr 13. Review.

5.

Purinergic responses of calcium-dependent signaling pathways in cultured adult human astrocytes.

Hashioka S, Wang YF, Little JP, Choi HB, Klegeris A, McGeer PL, McLarnon JG.

BMC Neurosci. 2014 Jan 22;15:18. doi: 10.1186/1471-2202-15-18.

6.

Long-term potentiation promotes proliferation/survival and neuronal differentiation of neural stem/progenitor cells.

Cho T, Ryu JK, Taghibiglou C, Ge Y, Chan AW, Liu L, Lu J, McLarnon JG, Wang YT.

PLoS One. 2013 Oct 17;8(10):e76860. doi: 10.1371/journal.pone.0076860. eCollection 2013.

7.

Upregulation and expression patterns of the angiogenic transcription factor ets-1 in Alzheimer's disease brain.

Jantaratnotai N, Ling A, Cheng J, Schwab C, McGeer PL, McLarnon JG.

J Alzheimers Dis. 2013;37(2):367-77. doi: 10.3233/JAD-122191.

PMID:
23948889
8.

Actions of the anti-angiogenic compound angiostatin in an animal model of Alzheimer's disease.

Ryu JK, Little JP, Klegeris A, Jantaratnotai N, McLarnon JG.

Curr Alzheimer Res. 2013 Mar;10(3):252-60.

PMID:
23534534
9.

Microglial chemotactic signaling factors in Alzheimer's disease.

McLarnon JG.

Am J Neurodegener Dis. 2012;1(3):199-204. Epub 2012 Nov 18.

10.

Metabolic communication between astrocytes and neurons via bicarbonate-responsive soluble adenylyl cyclase.

Choi HB, Gordon GR, Zhou N, Tai C, Rungta RL, Martinez J, Milner TA, Ryu JK, McLarnon JG, Tresguerres M, Levin LR, Buck J, MacVicar BA.

Neuron. 2012 Sep 20;75(6):1094-104. doi: 10.1016/j.neuron.2012.08.032.

11.

Mechanisms of Mg2+ inhibition of BzATP-dependent Ca2+ responses in THP-1 monocytes.

Jantaratnotai N, McGeer PL, McLarnon JG.

Brain Res. 2012 Mar 9;1442:1-8. doi: 10.1016/j.brainres.2012.01.004. Epub 2012 Jan 11.

PMID:
22297175
12.

Comparison of Vascular Perturbations in an Aβ-Injected Animal Model and in AD Brain.

Jantaratnotai N, Ryu JK, Schwab C, McGeer PL, McLarnon JG.

Int J Alzheimers Dis. 2011;2011:918280. doi: 10.4061/2011/918280. Epub 2011 Sep 29.

13.

Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease.

Franciosi S, Ryu JK, Shim Y, Hill A, Connolly C, Hayden MR, McLarnon JG, Leavitt BR.

Neurobiol Dis. 2012 Jan;45(1):438-49. doi: 10.1016/j.nbd.2011.09.003. Epub 2011 Sep 13.

PMID:
21946335
14.

Pyrazole compound 2-MBAPA as a novel inhibitor of microglial activation and neurotoxicity in vitro and in vivo.

Hashioka S, McLarnon JG, Ryu JK, Youssef AM, Abd-El-Aziz AS, Neeland EG, Klegeris A.

J Alzheimers Dis. 2011;27(3):531-41. doi: 10.3233/JAD-2011-110698.

PMID:
21841251
15.

Calcium dependence of purinergic subtype P2Y₁ receptor modulation of C6 glioma cell migration.

Jantaratnotai N, McLarnon JG.

Neurosci Lett. 2011 Jun 22;497(2):80-4. doi: 10.1016/j.neulet.2011.04.034. Epub 2011 Apr 22.

PMID:
21540076
16.

Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model.

Ryu JK, Jantaratnotai N, Serrano-Perez MC, McGeer PL, McLarnon JG.

J Neuropathol Exp Neurol. 2011 Jan;70(1):13-22. doi: 10.1097/NEN.0b013e318201d4d4.

PMID:
21157381
17.

Mg2+ ions reduce microglial and THP-1 cell neurotoxicity by inhibiting Ca2+ entry through purinergic channels.

Lee M, Jantaratnotai N, McGeer E, McLarnon JG, McGeer PL.

Brain Res. 2011 Jan 19;1369:21-35. doi: 10.1016/j.brainres.2010.10.084. Epub 2010 Oct 30.

PMID:
21040713
18.

Converging perturbed microvasculature and microglial clusters characterize Alzheimer disease brain.

Jantaratnotai N, Schwab C, Ryu JK, McGeer PL, McLarnon JG.

Curr Alzheimer Res. 2010 Nov;7(7):625-36.

PMID:
20704556
19.

Neural progenitor cells attenuate inflammatory reactivity and neuronal loss in an animal model of inflamed AD brain.

Ryu JK, Cho T, Wang YT, McLarnon JG.

J Neuroinflammation. 2009 Dec 23;6:39. doi: 10.1186/1742-2094-6-39.

20.

ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells.

Jantaratnotai N, Choi HB, McLarnon JG.

BMC Cancer. 2009 Dec 15;9:442. doi: 10.1186/1471-2407-9-442.

21.

Thalidomide inhibition of vascular remodeling and inflammatory reactivity in the quinolinic acid-injected rat striatum.

Ryu JK, Jantaratnotai N, McLarnon JG.

Neuroscience. 2009 Oct 6;163(2):601-8. doi: 10.1016/j.neuroscience.2009.07.006. Epub 2009 Jul 7.

PMID:
19591904
22.

Microglial VEGF receptor response is an integral chemotactic component in Alzheimer's disease pathology.

Ryu JK, Cho T, Choi HB, Wang YT, McLarnon JG.

J Neurosci. 2009 Jan 7;29(1):3-13. doi: 10.1523/JNEUROSCI.2888-08.2009.

23.

Lysophosphatidylcholine induces glial cell activation: role of rho kinase.

Sheikh AM, Nagai A, Ryu JK, McLarnon JG, Kim SU, Masuda J.

Glia. 2009 Jun;57(8):898-907. doi: 10.1002/glia.20815.

PMID:
19115379
24.

Relevance of abeta1-42 intrahippocampal injection as an animal model of inflamed Alzheimer's disease brain.

McLarnon JG, Ryu JK.

Curr Alzheimer Res. 2008 Oct;5(5):475-80. Review.

PMID:
18855589
25.

Block of purinergic P2X(7) receptor is neuroprotective in an animal model of Alzheimer's disease.

Ryu JK, McLarnon JG.

Neuroreport. 2008 Nov 19;19(17):1715-9. doi: 10.1097/WNR.0b013e3283179333.

PMID:
18852683
26.

A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain.

Ryu JK, McLarnon JG.

J Cell Mol Med. 2009 Sep;13(9A):2911-25. doi: 10.1111/j.1582-4934.2008.00434.x. Epub 2008 Jul 24.

27.
28.

Expression and function of the P2X(7) receptor in rat C6 glioma cells.

Wei W, Ryu JK, Choi HB, McLarnon JG.

Cancer Lett. 2008 Feb 18;260(1-2):79-87. Epub 2007 Nov 26.

PMID:
18039556
29.
30.
31.
32.
33.

Broad-spectrum effects of 4-aminopyridine to modulate amyloid beta1-42-induced cell signaling and functional responses in human microglia.

Franciosi S, Ryu JK, Choi HB, Radov L, Kim SU, McLarnon JG.

J Neurosci. 2006 Nov 8;26(45):11652-64.

34.
36.

Mitochondrial ligand inhibits store-operated calcium influx and COX-2 production in human microglia.

Hong SH, Choi HB, Kim SU, McLarnon JG.

J Neurosci Res. 2006 May 15;83(7):1293-8.

PMID:
16547968
37.
38.

Neuronal cell death induced by cystatin C in vivo and in cultured human CNS neurons is inhibited with cathepsin B.

Nagai A, Ryu JK, Terashima M, Tanigawa Y, Wakabayashi K, McLarnon JG, Kobayashi S, Masuda J, Kim SU.

Brain Res. 2005 Dec 20;1066(1-2):120-8. Epub 2005 Dec 2.

PMID:
16325785
39.

Induction of angiogenesis by platelet-activating factor in the rat striatum.

Tran KC, Ryu JK, McLarnon JG.

Neuroreport. 2005 Sep 28;16(14):1579-83.

PMID:
16148749
40.

Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients.

McLarnon JG, Choi HB, Lue LF, Walker DG, Kim SU.

J Neurosci Res. 2005 Aug 1;81(3):426-35.

PMID:
15948178
41.
42.
43.

Platelet-activating factor enhancement of calcium influx and interleukin-6 expression, but not production, in human microglia.

Sattayaprasert P, Choi HB, Chongthammakun S, McLarnon JG.

J Neuroinflammation. 2005 Apr 15;2(1):11.

44.

Induction of angiogenesis in the beta-amyloid peptide-injected rat hippocampus.

Zand L, Ryu JK, McLarnon JG.

Neuroreport. 2005 Feb 8;16(2):129-32.

PMID:
15671861
45.

IL-8 enhancement of amyloid-beta (Abeta 1-42)-induced expression and production of pro-inflammatory cytokines and COX-2 in cultured human microglia.

Franciosi S, Choi HB, Kim SU, McLarnon JG.

J Neuroimmunol. 2005 Feb;159(1-2):66-74. Epub 2004 Nov 26.

PMID:
15652404
46.

Minocycline inhibits neuronal death and glial activation induced by beta-amyloid peptide in rat hippocampus.

Ryu JK, Franciosi S, Sattayaprasert P, Kim SU, McLarnon JG.

Glia. 2004 Oct;48(1):85-90.

PMID:
15326618
47.

Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease.

Ryu JK, Kim J, Cho SJ, Hatori K, Nagai A, Choi HB, Lee MC, McLarnon JG, Kim SU.

Neurobiol Dis. 2004 Jun;16(1):68-77.

PMID:
15207263
49.

Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington's disease.

Ryu JK, Kim SU, McLarnon JG.

Exp Neurol. 2003 Oct;183(2):700-4.

PMID:
14552912
50.

Amyloid beta peptide-induced corpus callosum damage and glial activation in vivo.

Jantaratnotai N, Ryu JK, Kim SU, McLarnon JG.

Neuroreport. 2003 Aug 6;14(11):1429-33.

PMID:
12960758

Supplemental Content

Loading ...
Support Center